79th World Health Assembly Approves Global Equity Resolution – EHC
European Haemophilia Consortiumn (EHC), shared a post on LinkedIn:
“The 79th World Health Assembly has adopted a landmark resolution on ‘Global action to advance health equity for people with haemophilia and other bleeding disorders’.
This is a major step toward improving earlier diagnosis, ensuring equitable access to care and treatment, recognising women and girls with bleeding disorders, and strengthening national health systems for rare bleeding disorders worldwide.
In Europe, significant disparities in access to diagnosis, treatment, and comprehensive care persist both between and within countries.
The European Union (EU) has a critical role to play in closing these gaps.
The European Haemophilia Consortium (EHC) calls on the EU and its Member States to translate this global commitment into concrete action by strengthening rare disease policies, ensuring sustainable and equitable access to innovative therapies, and supporting coordinated, high-quality care across Europe.
EHC welcomes this momentum and stands with the international community in advancing sustainable, inclusive, and patient-centred care across Europe and beyond!”
Other posts featuring EHC on Hemostasis Today.
-
Oct 16, 2026, 13:59Aya Akmal Amin: Antiphospholipid Syndrome Management and Risk Stratification
-
Oct 16, 2026, 13:10Emanuel Sueldo: CAHT 2026 Celebrates Scientific Progress and Team Achievements
-
Oct 16, 2026, 13:05Maha Othman: Queen’s Health Sciences Advances CAT Risk Models and Pediatric ISTH-BAT Cut-Offs
-
Oct 16, 2026, 13:03Thrombosis Awareness Must Lead to Timely Action – Roche
-
Oct 16, 2026, 12:49Wolfgang Miesbach: 5-Year CBDR Data Confirms Emicizumab Safety and Efficacy in Hemophilia A
-
Oct 16, 2026, 12:40Edward Lee Carter: How Factor XI Inhibition Could Transform Anticoagulation Therapy
-
Oct 16, 2026, 12:40Marc Carrier: Looking Ahead to ISTH 2027 in Vancouver
-
Oct 16, 2026, 12:30Bob Lempke: How One Blood Donation Can Save Up to Three Lives
-
Oct 16, 2026, 12:30Why VWF Therapies Belong on the EU Critical Medicines List – EHC